Lyrica CR — Class II drug recall D-0851-2021
Terminated recall by Viatris, reported 2021-10-06, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0851-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Viatris, Morgantown, WV, United States |
| Recall initiated | 2021-08-23 |
| Classified | 2021-09-24 |
| Reported by FDA | 2021-10-06 |
| Terminated | 2022-09-07 |
| Distributed | Nationwide (US) |
| Quantity | 9,515 bottles |
| Reason classes | specification failure |
| NDC | 00071-1029-01 |
| Lot numbers | DN5396, EK2417, EP9726 |
| Expiration dates | 2022-08-20 |
Product
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0851-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.